Rating Rationale Brickwork Ratings reaffirms ‘BWR A+ (SO)’ for IDL Speciality Chemicals Ltd.’s Structured Secured NCD of ` 150 Cr with a present Outstanding of ` 75 Cr Brickwork Ratings (BWR) has reaffirmed the following Rating1 for IDL Speciality Chemicals Ltd. (IDL) structured secured NCD of ` 150 Cr having tenor up to 18 months. ‘BWR A+ (SO)’ stands for an instrument that is considered to have adequate degree of safety regarding timely servicing of financial obligations. Such instruments carry low credit risk. Of the ` 150 Cr NCD issue rated, the Company has redeemed NCDs aggregating to ` 75 Cr and the current outstanding portion is ` 75 Cr. Outstanding Ratings Instruments Secured NCD Amount Assigned/ Reaffirmed Rating (₹ Cr) 100 Issue Date Rating History Rating As on BWR A+ (SO) BWR A Plus Structured Obligation Withdrawn July, 2012 Withdrawn Outlook Stable BWR A+ (SO) BWR A Plus 150 Structured (Consists of series I & II BWR A+ (SO) Secured NCD Obligation Reaffirmed Dec, 2012 of ₹ 75 Cr each, of (Stable) which series II has already been paid) Outlook Stable BWR has essentially relied upon term sheet, information and clarification related to the transaction, as provided by the Issuer. The rating factors, inter alia, the strength of the underlying security coverage, structure of NCD issue and the profile of the Promoters. However, the rating is constrained by weak financial profile and insufficient cash flows of the Issuer. IDL Speciality Chemicals is a 100% subsidiary of HVL, which is the Media & Communications business of Hinduja Group. HVL provides cable television and broadband internet, local television programming, and movie channel and movie based programming services. IDL was incorporated in 1971 as IDL Agro Chemicals Ltd for manufacturing APIs and intermediates for cardiac, anti-depressants, anti-histamines, analgesic and anti-amoebic 1 Please refer to www.brickworkratings.com for definition of the Ratings www.brickworkratings.com 1 10 Mar 2014 drugs. It was merged with Gulf Oil India in 2002 to form Gulf Oil Corporation. In Sep 2009, Gulf Oil Corporation sold IDL’s bulk pharmaceutical business to Biocon Ltd. On 29th March, 2010, IDL was demerged from Gulf Oil Corporation and all its shares were acquired by HVL. Now the Company is having a small operation of dairy business and is also trading in equity market. The Company also owns 4.75 acres of land in Hyderabad which it plans to monetize it in near future. The Company has raised ` 150 Cr by way of secured redeemable NCD with a tenor of 18 months. Of which, NCD of Series I of ` 75 Cr to be repaid after 18 months from deemed date of allotment and Series II of ` 75 Cr has already been paid as investor has exercised the put option at the end of 12 months from deemed date of allotment. The NCD is secured through a first ranking exclusive charge over the Company pledged shares and parent pledged shares in favour of the Debenture Trustee such that there is a share cover of 1.75 times the face value of NCD. HVL has also given the shortfall undertaking in favour of Debenture Trustee. After HVL acquired IDL in Mar’10, it disposed of its earlier business of manufacturing APIs for Pharma industry. Trading in shares is now the dominant activity of IDL. It’s revenues decreased to ` 1.52 Cr in FY13 from ` 13.58 Cr in FY12 mainly due to unrealized profit from sale of securities. IDL continue to report losses in FY13 as it did in FY12. It has a negative net-worth due to negative reserves resulting from continued losses. As of FY13, IDL has a negative Net-worth and has been reporting losses for last four years. As such, the current as well as expected cash flows of IDL are not sufficient to meet the obligations of the balance NCD. IDL is engaged in the business of trading in Equity Shares which is arguably considered as a risky business. The macroeconomic outlook for India continues to remain challenging with high inflation, high fiscal deficit and slowing of capital investment plans. Given that the current cash flows from IDL is not sufficient to pay the obligations under the NCD, the support from Parent Company HVL (as manifested in the form of Shortfall Undertaking) and liquidity of share of Indusind Bank Ltd. remain the key Rating sensitivities. Analyst Contact Relationship Contact [email protected] [email protected] Phone Media Contact 1-860-425-2742 [email protected] Disclaimer: Brickwork Ratings (BWR) has assigned the rating based on the information obtained from the issuer and other reliable sources, which are deemed to be accurate. BWR has taken considerable steps to avoid any data distortion; however, it does not examine the precision or completeness of the information obtained. And hence, the information in this report is presented “as is” without any express or implied warranty of any kind. BWR does not make any representation in respect to the truth or accuracy of any such information. The rating assigned by BWR should be treated as an opinion rather than a recommendation to buy, sell or hold the rated instrument and BWR shall not be liable for any losses incurred by users from any use of this report or its contents. BWR has the right to change, suspend or withdraw the ratings at any time for any reasons. www.brickworkratings.com 2 10 Mar 2014
© Copyright 2024 ExpyDoc